Continuous Glucose Monitoring Metrics for Earlier Identification of Pre-diabetes: Protocol for a Systematic Review and Meta-analysis

Overview

Journal BMJ Open

Specialty General Medicine

Date 2022 Aug 25

PMID 36008066

Authors

Sara Gottfried

Laura Pontiggia

Andrew Newberg

Gregory Laynor

Daniel Monti

Affiliations

Soon will be listed here.

Abstract

Introduction: Glycaemic variability and other metrics are not well characterised in subjects without diabetes. More comprehensive sampling as obtained with continuous glucose monitoring (CGM) may improve diagnostic accuracy of the transition from health to pre-diabetes. Our goal is to investigate the glycaemic system as it shifts from health to pre-disease in adult patients without diabetes using CGM metrics. New insights may offer therapeutic promise for reversing dysglycaemia more successfully with dietary, nutritional and lifestyle change before progression occurs to pre-diabetes and diabetes.

Methods And Analysis: This systematic review will include comprehensive searches of the PubMed, Scopus, Cochrane Library and ClinicalTrials.gov databases, with restrictions set to studies published in the last 10 years in English and planned search date 10 March 2022. Reference lists of studies that meet eligibility criteria in the screening process will subsequently be screened for the potential inclusion of additional studies. We will include studies that examine CGM use and report diagnostic criteria such as fasting glucose and/or haemoglobin A1c such that we can assess correlation between CGM metrics and established diagnostic criteria and describe how CGM metrics are altered in the transition from health to pre-diabetes. The screening and data extraction will be conducted by two independent reviewers using Covidence. All included papers will also be evaluated for quality and publication bias using Cochrane Collaboration risk of bias tools. If there are two or more studies with quantitative estimates that can be combined, we will conduct a meta-analysis after assessing heterogeneity.

Ethics And Dissemination: The systematic review methodology does not require formal ethical review due to the nature of the study design. Study findings will be publicly available and published in a peer-reviewed journal.

Prospero Registration Number: CRD42022308222.

Citing Articles

Perioperative glucose monitoring with continuous glucose monitors identifies risk factors for post-transplant diabetes mellitus in kidney transplant recipients.

Shin J, Jo E, Woo H, Cho A, Ko M, Kim S Sci Rep. 2024; 14(1):21240.

PMID: 39261619 PMC: 11390710. DOI: 10.1038/s41598-024-72025-7.

Prediabetes in children and adolescents: An updated review.

Ng H, Chan L World J Clin Pediatr. 2024; 12(5):263-272.

PMID: 38178932 PMC: 10762598. DOI: 10.5409/wjcp.v12.i5.263.

ELSAH (electronic smart patch system for wireless monitoring of molecular biomarkers for healthcare and wellbeing): definition of possible use cases.

Brinkmann C, Bloch W, Mutinati G Front Bioeng Biotechnol. 2023; 11:1166857.

PMID: 37251564 PMC: 10211345. DOI: 10.3389/fbioe.2023.1166857.

References

Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M . Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002; 106(16):2067-72. DOI: 10.1161/01.cir.0000034509.14906.ae. View

Sampson M, Gopaul N, Davies I, Hughes D, Carrier M . Plasma F2 isoprostanes: direct evidence of increased free radical damage during acute hyperglycemia in type 2 diabetes. Diabetes Care. 2002; 25(3):537-41. DOI: 10.2337/diacare.25.3.537. View

Ceriello A, Hanefeld M, Leiter L, Monnier L, Moses A, Owens D . Postprandial glucose regulation and diabetic complications. Arch Intern Med. 2004; 164(19):2090-5. DOI: 10.1001/archinte.164.19.2090. View

Buscemi S, Re A, Batsis J, Arnone M, Mattina A, Cerasola G . Glycaemic variability using continuous glucose monitoring and endothelial function in the metabolic syndrome and in Type 2 diabetes. Diabet Med. 2010; 27(8):872-8. DOI: 10.1111/j.1464-5491.2010.03059.x. View

Lee D, Dreyfuss J, Sheehan A, Puleio A, Mulla C, Patti M . Glycemic Patterns Are Distinct in Post-Bariatric Hypoglycemia After Gastric Bypass (PBH-RYGB). J Clin Endocrinol Metab. 2021; 106(8):2291-2303. PMC: 8277212. DOI: 10.1210/clinem/dgab323. View

Wang C, Lv L, Yang Y, Chen D, Liu G, Chen L . Glucose fluctuations in subjects with normal glucose tolerance, impaired glucose regulation and newly diagnosed type 2 diabetes mellitus. Clin Endocrinol (Oxf). 2011; 76(6):810-5. DOI: 10.1111/j.1365-2265.2011.04205.x. View

Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol J . Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006; 295(14):1681-7. DOI: 10.1001/jama.295.14.1681. View

Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M . Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015; 4:1. PMC: 4320440. DOI: 10.1186/2046-4053-4-1. View

Ahn S, Kim H, Nam C, Suh I . Sex difference in the effect of the fasting serum glucose level on the risk of coronary heart disease. J Cardiol. 2017; 71(2):149-154. DOI: 10.1016/j.jjcc.2017.07.013. View

10.

Genuth S, Alberti K, Bennett P, Buse J, DeFronzo R, Kahn R . Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003; 26(11):3160-7. DOI: 10.2337/diacare.26.11.3160. View

11.

Thomas T, Golin C, Samuel-Hodge C, Kirkman M, Golden S, Lightfoot A . Race and gender differences in abnormal blood glucose screening and clinician response to prediabetes: A mixed-methods assessment. Prev Med. 2021; 148:106587. PMC: 8300953. DOI: 10.1016/j.ypmed.2021.106587. View

12.

Shepard J, Airee A, Dake A, McFarland M, Vora A . Limitations of A1c Interpretation. South Med J. 2015; 108(12):724-9. DOI: 10.14423/SMJ.0000000000000381. View

13.

Moore K . Glucose fluctuations and oxidative stress. JAMA. 2006; 296(14):1730. DOI: 10.1001/jama.296.14.1730-a. View

14.

Shaw J, Hodge A, de Courten M, Chitson P, Zimmet P . Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality. Diabetologia. 1999; 42(9):1050-4. DOI: 10.1007/s001250051269. View

15.

Siegelaar S, Holleman F, Hoekstra J, DeVries J . Glucose variability; does it matter?. Endocr Rev. 2009; 31(2):171-82. DOI: 10.1210/er.2009-0021. View

16.

Tseng E, Greer R, ORourke P, Yeh H, McGuire M, Albright A . National Survey of Primary Care Physicians' Knowledge, Practices, and Perceptions of Prediabetes. J Gen Intern Med. 2019; 34(11):2475-2481. PMC: 6848700. DOI: 10.1007/s11606-019-05245-7. View

17.

. Standards of medical care in diabetes--2007. Diabetes Care. 2006; 30 Suppl 1:S4-S41. DOI: 10.2337/dc07-S004. View

18.

Weykamp C . HbA1c: a review of analytical and clinical aspects. Ann Lab Med. 2013; 33(6):393-400. PMC: 3819436. DOI: 10.3343/alm.2013.33.6.393. View

19.

Bialasiewicz P, Pawlowski M, Nowak D, Loba J, Czupryniak L . Decreasing concentration of interstitial glucose in REM sleep in subjects with normal glucose tolerance. Diabet Med. 2009; 26(4):339-44. DOI: 10.1111/j.1464-5491.2009.02684.x. View

20.

Sterne J, Hernan M, Reeves B, Savovic J, Berkman N, Viswanathan M . ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016; 355:i4919. PMC: 5062054. DOI: 10.1136/bmj.i4919. View